FDA label
What is fludrocortisone acetate used for?
The FDA-approved uses of fludrocortisone acetate, quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label says: “Fludrocortisone acetate tablets, 0.1 mg are indicated as partial replacement therapy for primary and secondary adrenocortical insufficiency in Addison’s disease and for the treatment of salt-losing adrenogenital syndrome.”
Run it in Rivvi
Which 2027 plans near you dropped or restricted fludrocortisone acetate?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Fludrocortisone Acetate, tablet
Indications and Usage, quoted from the label by NCS HealthCare of KY, LLC dba Vangard Labs (ANDA040431). Cross-references to other label sections are left out.
Fludrocortisone acetate tablets, 0.1 mg are indicated as partial replacement therapy for primary and secondary adrenocortical insufficiency in Addison’s disease and for the treatment of salt-losing adrenogenital syndrome.
Source: DailyMed label, set id 3c007f9a-4cd5-4e74-a633-d55dde1fe903, version 19, effective February 27, 2026. NDC 0615-6562, one of 16 listings for this product.
Questions
What is fludrocortisone acetate used for?
The FDA label says: “Fludrocortisone acetate tablets, 0.1 mg are indicated as partial replacement therapy for primary and secondary adrenocortical insufficiency in Addison’s disease and for the treatment of salt-losing adrenogenital syndrome.”
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.